Elevated Serum CA-125 Levels in Hemodialysis Patients with Peritoneal, Pleural, or Pericardial Fluids

This publication has 17 references indexed in Scilit:

• Human Peritoneal Mesothelial Cells Are More Potent Than Ovarian Cancer Cells in Producing Tumor Marker CA-125
  Gynecologic Oncology, 1996
• The Effect of Renal Function on Serum Levels of CA 125
  Gynecologic Oncology, 1995
• Serum CA-125 Level in End-Stage Renal Disease Patients Maintained on Chronic Peritoneal Dialysis or Hemodialysis: The Effect of Continuous Presence of Peritoneal Fluid, Peritonitis, and Peritoneal Catheter Implantation
  American Journal of Nephrology, 1995
• What do we know about the origin of CA 125?
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1993
• Tumor Markers in Chronic Renal Failure and Hemodialysis Patients
  Nephron, 1991
• Tumor Markers in Patients Undergoing Hemodialysis or Kidney Transplantation
  Nephron, 1991
• Effect of Hemodialysis on the Concentration of the Seven Tumor Markers Carcinoembryonic Antigen, Alpha-Fetoprotein, Squamous Cell Carcinoma-Related Antigen, Neuron-Specific Enolase, CA 125, CA19–9 and CA 15–3 in Uremic Patients
  American Journal of Nephrology, 1991
• Tumormarker bei dialysepflichtiger Niereninsuffizienz
  Oncology Research and Treatment, 1988
• Low serum CA125 concentration in chronic renal failure treated with continuous ambulatory peritoneal dialysis
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1987
• Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125
  International Journal of Gynecological Pathology, 1983